Indian Thalidomide Exporters: Complete Supplier Ranking with Market Share — 153 Manufacturers (2026) — TransData Nexus

Q: Who is the largest thalidomide supplier from India?

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the largest thalidomide exporter from India with a 24.2% market share and export value of $468.6K.

Q: How many thalidomide suppliers are there in India?

There are 153 active thalidomide exporters in India, collectively shipping $1.9M worth of thalidomide across 822 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top thalidomide suppliers from India?

The top 5 thalidomide suppliers from India — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, KANCHAN SAGAR PHARMACEUTICALS — together control 65.9% of total thalidomide export value from India.

Suresh Sormare

Thalidomide

India Pharmaceutical Trade Intelligence

$1.9M153 Suppliers92 CountriesHS 30049049

ExportsIndia → ALGERIA26.8%India → SRI LANKA14.5%

ImportsUNITED KINGDOM → India$105

#1 Supplier: BDR PHARMACEUTICALS #1 Buyer: SOFTCARE INTERNATIONAL(PVT)LTD

Thalidomide Suppliers from India (2026) — 153 Exporters, $1.9M Market | TransData Nexus | TransData Nexus

Who Exports Thalidomide from India — 153 Suppliers Behind a $1.9M Market

India's thalidomide export market is supplied by 153 active exporters who collectively shipped $1.9M across 822 shipments. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED leads with a 24.2% market share, followed by UNITED BIOTECH PRIVATE LIMITED and JODAS EXPOIM PRIVATE LIMITED. The top 5 suppliers together control 65.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Thalidomide Suppliers & Exporters — 153 manufacturers, $1.9M export market, top destinations and formulations — Thalidomide supplier data — 153 exporters · $1.9M market · 822 shipmentsTransData Nexus · Indian Customs Data

Top Thalidomide Exporters from India — Ranked by Export Value

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the leading thalidomide exporter from India, holding a 24.2% share of the $1.9M market across 822 shipments from 153 exporters. The top 5 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, KANCHAN SAGAR PHARMACEUTICALS — collectively control 65.9% of total export value, indicating a moderately concentrated market. Individual shares are: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (24.2%), UNITED BIOTECH PRIVATE LIMITED (15.9%), JODAS EXPOIM PRIVATE LIMITED (13.3%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (7.4%), KANCHAN SAGAR PHARMACEUTICALS (5.1%).

Top Thalidomide Exporters from India

Ranked by export value · 153 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Thalidomide Exporters from India — Ranked by Export Value. 153 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Thalidomide exporters

Certification and compliance status for top Thalidomide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Sun Pharmaceutical Industries Limited	Warning Letter, December	Yes, as of 2015	Yes	Not verified	Received FDA warning letter in 2015 for CGMP violations at Halol facility.
Hetero Labs Limited	Warning Letter, March 202	Yes, as of 2025	Yes	Not verified	Received FDA warning letter in 2025 for CGMP violations at Hyderabad facility.
BDR Pharmaceuticals International Private Limited	Not Listed	Yes, as of 2024	Yes	Not verified	Holds WHO-GMP and EU GMP certifications as of 2024.
Jodas Expoim Private Limited	Not Listed	Yes, as of 2023	Yes	Not verified	Holds WHO-GMP and EU GMP certifications as of 2023.
United Biotech Private Limited	Not Listed	Yes, as of 2022	Yes	Not verified	Holds WHO-GMP and EU GMP certifications as of 2022.
Kanchan Sagar Pharmaceuticals	Not Listed	Yes, as of 2023	Yes	Not verified	Holds WHO-GMP and EU GMP certifications as of 2023.
Accure Labs Private Limited	Not Listed	Yes, as of 2024	Yes	Not verified	Holds WHO-GMP and EU GMP certifications as of 2024.
3S Pharmaceuticals India Private Limited	Not Listed	Yes, as of 2023	Yes	Not verified	Holds WHO-GMP and EU GMP certifications as of 2023.

TransData Nexus reviewed the regulatory standing of 8 leading Thalidomide exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Thalidomide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as India's "Bulk Drug Capital," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical landscape is anchored by Genome Valley, a hub for R&D and biologics, and Hyderabad Pharma City, an emerging integrated cluster aimed at consolidating APIs, formulations, and support services. This robust infrastructure positions Hyderabad as a pivotal player in the production of APIs like Thalidomide.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations. This region hosts major companies such as Torrent Pharmaceuticals, Zydus Cadila Healthcare, and Intas Pharmaceuticals, all of which have substantial manufacturing facilities. The presence of these industry leaders underscores the region's capacity for producing finished pharmaceutical products, including Thalidomide formulations.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. Mumbai, being the headquarters of Sun Pharmaceutical Industries Limited, the largest pharmaceutical company in India, plays a central role in the export of pharmaceuticals. The region's well-established logistics and port facilities facilitate the efficient export of drugs like Thalidomide to international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Thalidomide exporters from India

April 2025

Capacity Expansion

BDR Pharmaceuticals International Private Limited — BDR Pharmaceuticals plans $100 million US manufacturing expansion

BDR Pharmaceuticals announced plans to invest $100 million in acquiring manufacturing facilities in the United States to enhance its presence in the US market. The company is evaluating potential units and expects to finalize acquisitions within three to four months, funding the expansion through internal accruals. - IMPACT: This expansion may bolster BDR's production capabilities, potentially increasing Thalidomide exports.

Impact: This expansion may bolster BDR's production capabilities, potentially increasing Thalidomide exports.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharma acquired Checkpoint Therapeutics, a US-based immunotherapy and targeted oncology company, for $355 million. This acquisition includes UNLOXCYT (cosibelimab), an FDA-approved anti-PD-L1 treatment for skin cancer, enhancing Sun Pharma's oncology portfolio and US market presence. (pedb.uk) - IMPACT: The acquisition strengthens Sun Pharma's oncology offerings, which may indirectly influence Thalidomide export strategies.

Impact: The acquisition strengthens Sun Pharma's oncology offerings, which may indirectly influence Thalidomide export strategies.

Common Questions — Thalidomide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which thalidomide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED leads with 23 recorded shipments worth $468.6K. UNITED BIOTECH PRIVATE LIMITED (18 shipments) and JODAS EXPOIM PRIVATE LIMITED (12 shipments) are also established high-volume exporters.

Q How many thalidomide manufacturers are there in India?

India has 153 active thalidomide exporters with a combined export market of $1.9M across 822 shipments to 92 countries. The top 5 suppliers hold 65.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for thalidomide from India?

Average FOB unit price: $8.66 per unit, ranging from $0.10 to $206.67. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Thalidomide

Thalidomide

Who Exports Thalidomide from India — 153 Suppliers Behind a $1.9M Market

Top Thalidomide Exporters from India — Ranked by Export Value

Top Thalidomide Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

BDR Pharmaceuticals International Private Limited — BDR Pharmaceuticals plans $100 million US manufacturing expansion

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Thalidomide Suppliers from India

Q Which thalidomide supplier from India is the most reliable for bulk orders?

Q How many thalidomide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for thalidomide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — Sun Pharma completes merger with Taro Pharmaceuticals

Analysis Methodology